Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares Repurchased
Ratios

Definitive Healthcare (DH) Shares Outstanding (2021 - 2026)

Definitive Healthcare filings provide 5 years of Shares Outstanding readings, the most recent being $38.3 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding fell 2.63% to $38.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $38.3 million, a 2.63% decrease, with the full-year FY2025 number at $38.3 million, down 2.63% from a year prior.
  • Shares Outstanding hit $38.3 million in Q4 2025 for Definitive Healthcare, down from $103.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $117.8 million in Q1 2024 to a low of $249225.0 in Q3 2024.
  • Median Shares Outstanding over the past 5 years was $50.6 million (2021), compared with a mean of $61.0 million.
  • Biggest five-year swings in Shares Outstanding: soared 190.19% in 2024 and later tumbled 97.36% in 2025.
  • Definitive Healthcare's Shares Outstanding stood at $97.0 million in 2021, then increased by 8.36% to $105.1 million in 2022, then rose by 10.87% to $116.6 million in 2023, then crashed by 66.22% to $39.4 million in 2024, then decreased by 2.63% to $38.3 million in 2025.
  • The last three reported values for Shares Outstanding were $38.3 million (Q4 2025), $38.3 million (Q3 2025), and $1.0 million (Q2 2025) per Business Quant data.